Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study

  1. Castillo, N.
  2. García-García, P.
  3. Rivero, A.
  4. Jiménez-Sosa, A.
  5. MacÍa, M.
  6. Getino, M.A.
  7. Méndez, M.L.
  8. García-Pérez, J.
  9. Navarro-González, J.F.
Aldizkaria:
BMC Nephrology

ISSN: 1471-2369

Argitalpen urtea: 2012

Alea: 13

Zenbakia: 1

Mota: Artikulua

DOI: 10.1186/1471-2369-13-60 GOOGLE SCHOLAR lock_openSarbide irekia editor